Comparative cardiometabolic effects of fibrates and omega-3 fatty acids
- 10 September 2013
- journal article
- research article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 167 (6), 2404-2411
- https://doi.org/10.1016/j.ijcard.2013.01.223
Abstract
No abstract availableThis publication has 98 references indexed in Scilit:
- n–3 Fatty Acids and Cardiovascular Outcomes in Patients with DysglycemiaThe New England Journal of Medicine, 2012
- n–3 Fatty Acids and Cardiovascular Events after Myocardial InfarctionThe New England Journal of Medicine, 2010
- Cardiovascular effects of marine omega-3 fatty acidsThe Lancet, 2010
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysisThe Lancet, 2010
- Combination therapy for treatment or prevention of atherosclerosis: Focus on the lipid-RAAS interactionAtherosclerosis, 2010
- Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetesAtherosclerosis, 2009
- Omega‐3 Dietary Supplements and the Risk of Cardiovascular Events: A Systematic ReviewClinical Cardiology, 2009
- Vascular and metabolic effects of treatment of combined hyperlipidemia: Focus on statins and fibratesInternational Journal of Cardiology, 2008
- Dietary supplementation with ω-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overloadCardiovascular Research, 2007
- Inflammatory Markers and the Metabolic Syndrome: Insights From Therapeutic InterventionsJournal of the American College of Cardiology, 2005